Interleukin-4 distinctively modifies responses of germinal centre-like and activated B-cell-like diffuse large B-cell lymphomas to immuno-chemotherapy. [electronic resource]
Producer: 20100223Description: 308-18 p. digitalISSN:- 1365-2141
- Antibiotics, Antineoplastic -- pharmacology
- Antibodies, Monoclonal -- pharmacology
- Antibodies, Monoclonal, Murine-Derived
- Antineoplastic Agents -- pharmacology
- Apoptosis -- drug effects
- Apoptosis Regulatory Proteins -- biosynthesis
- Doxorubicin -- pharmacology
- Drug Evaluation, Preclinical -- methods
- Germinal Center -- pathology
- Humans
- Interleukin-4 -- pharmacology
- Lymphocyte Activation
- Lymphoma, Large B-Cell, Diffuse -- metabolism
- Neoplasm Proteins -- biosynthesis
- Phosphatidylinositol 3-Kinases -- physiology
- Recombinant Proteins -- pharmacology
- Rituximab
- Tumor Cells, Cultured
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.